Libero Thera
Delivering advanced drug discovery and development services, specializing in GPCRs for membrane proteins since 2018, based in Tokyo.
est. 2018
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
20 employees · est. 2018 · Houston, United States
Side-by-Side Comparison
| Metric | Libero Thera | Marker Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2018 |
| Headquarters | ||
| Headquarters | Not tracked yet | Houston, United States |
| Employees | ||
| Employees | Not tracked yet | 20 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series Unknown | Grant |
| Total Funding | ||
| Total Funding | $535.00M | $98.60M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Not tracked yet | Development of Multi-Antigen Recognizing (MAR) T cell therapies, Clinical trials for novel therapies, Research and development in immunotherapy |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with lymphoma, Individuals with blood cancers, Patients with solid tumors, Healthcare providers, Medical researchers |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Development Services, GPCRs, Membrane Proteins, Pharmaceuticals, Tokyo, Biopharmaceuticals | Immuno-Oncology, T Cell-based Immunotherapies, Hematological Malignancies, Solid Tumor Indications, Multi-antigen Approach, Non-engineered T Cells, Tumor-associated Antigens, Cell Therapy Technology, Cost-effective Manufacturing, Reduced Toxicity, Clinical-stage Company, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Adoptive T Cell Therapy |
| Website | ||
| Website | liberothera.com | markertherapeutics.com |
About Libero Thera
Libero Thera, **founded in 2018**, is a biopharma and biotechnology company based in Tokyo, Japan. The company specializes in **delivering advanced drug discovery and development services**, with a focus on drugs involving GPCRs for membrane proteins. In May 2021, the company secured a significant *...
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc., founded in 2018, is making significant strides in the fields of Biotechnology and Health and Wellness. Headquartered in the United States, the company is driven by the slogan "Pioneering a Multi-Antigen Approach," focusing on the development of advanced T cell-based immuno...
We will tell you when either one moves
BounceWatch watches Libero Thera and Marker Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Libero Thera and Marker Therapeutics, I... — by email.
Frequently Asked Questions
Compare Libero Thera with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Libero Thera on 12 Sep 2024, and Marker Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
